Las Vegas Sands has confirmed that Sheldon Adelson, the company’s chairman and CEO, is to take a leave of absence from the group on medical grounds.
The companies’ boards of directors have named Robert Goldstein, who currently serves as Las Vegas Sands’ president and chief operating officer, as acting chairman and acting chief executive officer of both Las Vegas Sands and Sands China while Adelson is on medical leave.
In a media statement, the company confirmed: “In March of 2019, Las Vegas Sands chairman and chief executive officer Sheldon Adelson announced he was receiving treatment for non-Hodgkin’s lymphoma.
“Mr Adelson recently resumed his cancer treatment and will be taking a leave of absence as of today from his role as chairman and chief executive officer of both Las Vegas Sands and Sands China.”
In an overview provided by the NHS, it is stressed that most cases of non-Hodgkin lymphoma are considered very treatable. Non-Hodgkin lymphoma can occur at any age, but the chances of developing the condition increase as you get older, with just over a third of cases diagnosed in people over 75.
It is added that treatment and outlook “varies greatly, depending on the exact type, grade and extent of the lymphoma, and the person’s age.
“Low-grade tumours don’t necessarily require immediate medical treatment, but are harder to completely cure. High-grade lymphomas need to be treated straight away, but tend to respond much better to treatment and can often be cured.”
